NCT05333458 2026-03-19Testing Atezolizumab With Selinexor in People ≥ 12 Years Old With Alveolar Soft Part Sarcoma, The AXIOM TrialNational Cancer Institute (NCI)Phase 2 Recruiting27 enrolled
NCT06169215 2026-03-18Comparing the Combination of Selinexor-Daratumumab-Velcade-Dexamethasone (Dara-SVD) With the Usual Treatment (Dara-RVD) for High-Risk Newly Diagnosed Multiple MyelomaNational Cancer Institute (NCI)Phase 2 Active not recruiting70 enrolled